Clinical Trial Details
EORTC-1522-QLG
Back to Clinical Trials Database
Development of an EORTC questionnaire for individuals at risk for a Hereditary Cancer Predisposition Syndrome : the EORTC QLQ-HCPSxx
| Trial Status | Recruiting |
|---|---|
| Dates |
Date of activation: 15-May-2017 |
| Data management at EORTC | None |
| Design |
QoL Mod. development Not randomized / N.A. |
| Treatment | |
| Study Staff |
Anne Oberguggenberger (Study Coordinator) , A.O Landeskrankenhaus - Innsbruck Universitaetsklinik, Innsbruck Vasilios Vasiliou (Study Coordinator) , Bank Of Cyprus Oncology Centre, Strovolos - Nicosia Melanie Beauvois (Clinical Operations Manager) , EORTC Headquarters, Brussels Monika Sztankay (Study Co-Coordinator) , A.O Landeskrankenhaus - Innsbruck Universitaetsklinik, Innsbruck |
| Type of cancer | |
| Participating groups | EORTC Quality of Life Group |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number | |
| Financial Support | EORTC Group |
